NEW YORK (Reuters Health) - Asian patients who are treated with anti-clotting drugs, also called “anti-thrombotics,” after having a heart attack are more likely than their white counterparts to experience bleeding complications, new research suggests.As lead investigator Dr. Tracy Y. Wang told Reuters Health, “Asian patients...are more likely to bleed. This may partly be due to more overdosing in this group, but raises the concern that there may be ethnic differences in the patient’s response to therapy.”
